发明名称 Cardiac glycoside compsns. with good enteric resorption - with the glycoside dissolved or suspended in (mixed) fatty acid partial glycerides
摘要 <p>Compsn. consists of a soln. or microcrystalline suspension of cardiac glycosides (I) in partial glycerides (II) of medium chain-length fatty acids, or mixts. of glycerides. Pref. (II) are mono-and/or di-glycerides and the acid component has 6-12, esp. 8-10C. Suitably the compsns. are treated with an auxiliary to increase the viscosity or give it structure, and then filled into a gelatin capsule, opt. coated with a substance resistant to gastric acid. alternatively they are made up as suppositories. Compsn. is used for treatment of cardiac insufficiency. Compsns. has very high (=80%) enteric resorption for (I) which are normally very difficulty resorbable, e.g. strophanthin g or k, and proscillaridine. LD50's are lower in (II), e.g. for strophanthin g it is 5.2 mg/kg c.f. 34.8 mg-kg in water (orally in guinea pigs).</p>
申请公布号 NL7707567(A) 申请公布日期 1978.01.16
申请号 NL19770007567 申请日期 1977.07.07
申请人 KALI-CHEMIE PHARMA GMBH TE HANNOVER, BONDSREPUBLIEK DUITSLAND. 发明人
分类号 A61K9/02;A61K9/48;A61K47/14;(IPC1-7):61K31/705 主分类号 A61K9/02
代理机构 代理人
主权项
地址